RIGL - Rigel Pharmaceuticals GAAP EPS of $1.46 beats by $0.56, revenue of $69.46M beats by $7.58M
2025-11-04 16:24:30 ET
More on Rigel Pharmaceuticals
- Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion
- Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout
- Seeking Alpha’s Quant Rating on Rigel Pharmaceuticals
- Historical earnings data for Rigel Pharmaceuticals
- Financial information for Rigel Pharmaceuticals